NCT07458360 FRONT Block for Quality of Recovery After Total Hip Arthroplasty
| NCT ID | NCT07458360 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Konya Meram State Hospital |
| Condition | Osteoarthritis of the Hip |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-04-25 |
| Primary Completion | 2026-12-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-04-25 with a primary completion date of 2026-12-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized controlled trial evaluates the effect of ultrasound-guided unilateral Femoral Rami and Obturator Nerve Trunk (FRONT) block on postoperative quality of recovery in patients undergoing elective total hip arthroplasty.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Scheduled for total hip arthroplasty under spinal anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Ability to understand and complete the QoR-15 questionnaire * Provided written informed consent Exclusion Criteria: * Refusal to participate * Contraindication to spinal anesthesia or regional block * Allergy to study medications * Chronic opioid use (daily use for more than 3 months) * Neurological or neuromuscular disorders affecting the lower extremities * Infection at the injection site * Coagulation disorders * Cognitive impairment prevents questionnaire completion
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07458360 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis of the Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07458360 currently recruiting?
Yes, NCT07458360 is actively recruiting participants. Contact the research team at betulkozanhan@gmail.com for enrollment information.
Where is the NCT07458360 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT07458360 clinical trial?
NCT07458360 is sponsored by Konya Meram State Hospital. The trial plans to enroll 80 participants.